Lakefront Biotherapeutics NV (AMS:LKFT)

Netherlands · Delayed Price · Currency is EUR

25.80

+0.52 (2.06%)

At close: Jun 26, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development (R&D)	1.11B	275.65M	239.72M	241.25M	234.38M
Research and Development (R&D) Growth	303.50%	14.99%	-0.63%	2.93%	-50.97%
Total	1.11B	275.65M	239.72M	241.25M	234.38M
Total Growth	303.50%	14.99%	-0.63%	2.93%	-50.97%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States of America	1.08B	240.79M	239.71M	241.15M	234.34M
United States of America Growth	349.01%	0.45%	-0.60%	2.91%	-50.40%
Europe	31.10M	34.86M	16.00K	100.00K	43.00K
Europe Growth	-10.78%	217793.75%	-84.00%	132.56%	-99.23%
Total	1.11B	275.65M	239.72M	241.25M	234.38M
Total Growth	303.50%	14.99%	-0.63%	2.93%	-50.97%